Characteristic effect of an anticancer dinuclear platinum(II) complex on the higher-order structure of DNA.
It is known that a 1,2,3-triazolato-bridged dinuclear platinum(II) complex, [{cis-Pt(NH(3))(2)}(2)(micro-OH)(micro-1,2,3-ta-N (1),N (2))](NO(3))(2) (AMTA), shows high in vitro cytotoxicity against several human tumor cell lines and circumvents cross-resistance to cisplatin. In the present study, we examined a dose- and time-dependent effect of AMTA on the higher-order structure of a large DNA, T4 phage DNA (166 kbp), by adapting single-molecule observation with fluorescence microscopy. It was found that AMTA induces the shrinking of DNA into a compact state with a much higher potency than cisplatin. From a quantitative analysis of the Brownian motion of individual DNA molecules in solution, it became clear that the density of a DNA segment in the compact state is about 2,000 times greater than that in the absence of AMTA. Circular dichroism spectra suggested that AMTA causes a transition from the B to the C form in the secondary structure of DNA, which is characterized by fast and slow processes. Electrophoretic measurements indicated that the binding of AMTA to supercoiled DNA induces unwinding of the double helix. Our results indicate that AMTA acts on DNA through both electrostatic interaction and coordination binding; the former causes a fast change in the secondary structure from the B to the C form, whereas the latter promotes shrinking in the higher-order structure as a relatively slow kinetic process. The shrinking effect of AMTA on DNA is attributable to the possible increase in the number of bridges along a DNA molecule. It is concluded that AMTA interacts with DNA in a manner markedly different from that of cisplatin.
Osaka University of Pharmaceutical Sciences, Takatsuki, Japan.
Naoko
N
Kida
Yousuke
Y
Katsuda
Yuko
Y
Yoshikawa
Seiji
S
Komeda
Takaji
T
Sato
Yoshihiro
Y
Saito
Masahiko
M
Chikuma
Mari
M
Suzuki
Tadayuki
T
Imanaka
Kenichi
K
Yoshikawa
D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology*; D017122:Bacteriophage T4 / Q000737:chemistry; D004279:DNA, Viral / Q000737:chemistry* / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D008856:Microscopy, Fluorescence; D015394:Molecular Structure; D009690:Nucleic Acid Conformation / Q000187:drug effects*; D009942:Organometallic Compounds / Q000737:chemistry / Q000494:pharmacology*; D010984:Platinum / Q000737:chemistry* / Q000494:pharmacology; D013997:Time Factors
D000970:Antineoplastic Agents; D004279:DNA, Viral; D009942:Organometallic Compounds; D010984:Platinum